Gujarat Kidney N SUP SP L
NSE: GKSL · Hospital · sector
₹177.57NSE close 2026-10-26
Key numbers
Market cap₹1,055 cr
Price₹177.57
52w high / low₹210 / ₹98
P/E70.8xSector median 42.5x
P/B4.2xSector median 4.9x
Book value₹42.5
Dividend yield–Sector median 0.17%
ROE6.3%Sector median 12.1%
ROCE8.6%Sector median 13.8%
OPM26.4%Sector median 20.3%
Debt / equity0.06xSector median 0.24x
EV/EBITDA38.0xSector median 23.6x
Interest cover9.8x
Current ratio3.76x
Sales growth 3y–Sector median +14.1%
Profit growth 3y–Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹56 cr vs borrowings ₹16 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 9.8x in the last 12 months.
- Other income was 10% of net profit in the last 12 months.
- No dividend in the last 1 financial years.
- Price ₹177.57 on 2026-10-26: -15.4% from the 52-week high, +80.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹194.27 · low ₹101.72
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 13 | 23 | 31 | 34 |
| EBITDA | 5 | 7 | 6 | 8 |
| OPM % | 39.6% | 29.6% | 20.6% | 24.4% |
| Other income | 0 | 0 | 1 | 1 |
| Net profit | 3 | 3 | 5 | 5 |
| EPS (₹) | 0.52 | 0.52 | 0.81 | 0.66 |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 82 | 101 |
| EBITDA | 27 | 27 |
| Net profit | 16 | 16 |
| EPS (₹) | 2.49 | 2.51 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 253 |
| Borrowings | 16 |
| Cash & equivalents | 56 |
| Total assets | 298 |
| Fixed assets | 27 |
| Investments | 0 |
| Receivables | 39 |
| Inventory | 2 |
| Payables | 8 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | -4 |
| Cash from investing | -214 |
| Cash from financing | 228 |
| Capex | 11 |
| Free cash flow | -15 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 6.1% |
| ROCE % | 8.6% |
| Debtor days | 172 |
| Inventory days | 82 |
| Payable days | 339 |
| Cash conversion cycle (days) | -85 |
| Working capital days | 342 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 71.45% |
| FIIs | 6.53% |
| DIIs | 0.26% |
| of which Mutual funds | 0.00% |
| of which Insurance | 0.00% |
| Government | 0.00% |
| Public (non-institutions) | 21.77% |
| Quarter | Dec 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters % | 71.45% | 71.45% | 71.45% | 71.45% | 71.45% |
| Promoter group | % |
|---|---|
| Pragnesh Yashwantsinh Bharpoda | 38.16% |
| Anitaben Nayak | 11.10% |
| Yashwantsingh Motisingh Bharpoda | 11.10% |
| Bhartiben Pragnesh Bharpoda | 11.10% |
| Nikita Yashvantsinh Bharpoda | 0.00% |
| Vihan Bharpoda | 0.00% |
| Aarya Bharpoda | 0.00% |
| Karansinh Surendrasinh Padwal | 0.00% |
| Sumanben K Padwal | 0.00% |
| Hitendrasinh K Padwal | 0.00% |
| Tikamsinh Bharpoda | 0.00% |
| Chatrasinh Bharpoda | 0.00% |
| Sampatben S Khasariya | 0.00% |
| Public holders above 1% | % |
|---|---|
| Goldman Sachs Investments (Mauritius) I Ltd | 3.50% |
| Ashika Global Finance Private Limited | 1.27% |
| Citadel Securities India Markets Pvt Ltd | 1.17% |
12,986 shareholders. Pledged: – of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| GKSL | ₹1,055 cr | 70.8x | 4.2x | 6.3% | 8.6% | 26.4% | – | – |
Documents
- Annual report FY26
- Annual report FY26
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | GKSL |
| BSE code | 544666 |
| ISIN | INE0V0W01025 |
| Face value | ₹2.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.